Literature DB >> 13751307

Immunologic studies of heart tissue. IV. Serologic reactions with human heart tissue as revealed by immunofluorescent methods: isoimmune, Wassermann, and autoimmune reactions.

M H KAPLAN, M MEYESERIAN, I KUSHNER.   

Abstract

Reactions of normal and pathologic sera with heart tissue have been investigated by the immunofluorescent method, with particular reference to presumptive autoantibodies to heart and their differentiation from blood group isoantibodies and Wassermann antibody. In the heart, blood group substances A and B were found distributed in capillary walls, vascular endothelium, and interstitial connective tissue. In surveys of randomly selected sera, isoimmune reactions against tissue blood group substances A and B were noted infrequently. This finding was considered related to the limited sensitivity of fluorescent antibody methods. Heart tissue from blood group O individuals was used for screening of pathologic sera for presence of tissue-reactive factors. Wassermann antibody was found reactive with constituents of myocardial sarcoplasm, of which the major reactant was cardiolipin. Wassermann-positive sera absorbed with beef cardiolipin gave evidence of reaction with other constituents of myofiber sarcoplasm. Sera of patients with rheumatic fever, rheumatic heart disease, rheumatoid arthritis, disseminated lupus, and liver disease frequently showed a marked reactivity with constituents of myofiber sarcoplasm. These serum factors were differentiated from Wassermann antibody. At least three patterns of immunofluorescent staining could be differentiated by the distribution of reactants in the myofiber sarcoplasm. These reactants were extractable with ethanol and methanol but not by acetone. Sera found reactive by immunofluorescence frequently gave positive flocculation and complement-fixation tests with alcohol extracts of human heart. Immunofluorescent tests were best correlated with flocculation reactions. Sarcoplasmic-reactive factors were associated in some sera with 19S gamma globulin as demonstrated by the use of fluorescent anti-19S gamma globulin. Serologic reactions with homologous or autologous heart were observed particularly frequently with sera from rheumatic patients approximately 2 weeks following cardiac surgery, as well as in some non-rheumatic patients following cardiac or thoracic surgery or acute myocardial infarction. The pathogenetic significance of these presumptive autoantibodies to heart is unknown. As yet, no definite conclusions may be drawn regarding their relationship to bound gamma globulin in rheumatic hearts or to the postcardiotomy and post-infarction syndromes.

Entities:  

Keywords:  ANTIEMETICS/therapy; HEART DEFECTS, CONGENITAL/pathology; RHEUMATIC HEART DISEASE/pathology

Mesh:

Substances:

Year:  1961        PMID: 13751307      PMCID: PMC2137332          DOI: 10.1084/jem.113.1.17

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Isothiocyanate compounds as fluorescent labeling agents for immune serum.

Authors:  J L RIGGS; R J SEIWALD; J H BURCKHALTER; C M DOWNS; T G METCALF
Journal:  Am J Pathol       Date:  1958 Nov-Dec       Impact factor: 4.307

2.  Immunologic studies of heart tissue. I. Production in rabbits of antibodies reactive with an autologous myocardial antigen following immunization with heterologous heart tissue.

Authors:  M H KAPLAN
Journal:  J Immunol       Date:  1958-04       Impact factor: 5.422

3.  [Antibodies against various tissue cells in rheumatic and other diseases].

Authors:  K R BUTLER; S MOESCHLIN
Journal:  Helv Med Acta       Date:  1956-11

4.  Antimyocardial antibodies in rheumatic fever.

Authors:  V REJHOLEC; V WAGNER
Journal:  Experientia       Date:  1955-07-15

5.  Diagnostic complement fixation. I. A method.

Authors:  A G OSLER; J H STRAUSS; M M MAYER
Journal:  Am J Syph Gonorrhea Vener Dis       Date:  1952-03

6.  [Animal experiments on an allergotuberculous myocarditis].

Authors:  E FRICK
Journal:  Z Gesamte Exp Med       Date:  1951

7.  Results of the surgical treatment for mitral stenosis; analysis of one hundred consecutive cases.

Authors:  O H JANTON; R P GLOVER; T J E O'NEILL; J E GREGORY; G F FROIO
Journal:  Circulation       Date:  1952-09       Impact factor: 29.690

8.  Macroglobulinemia. II. Antisera specific for pathological macroglobulins.

Authors:  L KORNGOLD; G VAN LEEUWEN
Journal:  J Exp Med       Date:  1957-10-01       Impact factor: 14.307

9.  Localization of antigen in tissue cells; improvements in a method for the detection of antigen by means of fluorescent antibody.

Authors:  A H COONS; M H KAPLAN
Journal:  J Exp Med       Date:  1950-01-01       Impact factor: 14.307

10.  Immunologic studies of heart tissue. III. Occurrence of bound gamma globulin in auricular appendages from rheumatic hearts. Relationship to certain histopathologic features of rheumatic heart disease.

Authors:  M H KAPLAN; F D DALLENBACH
Journal:  J Exp Med       Date:  1961-01-01       Impact factor: 14.307

View more
  14 in total

1.  HEART MUSCLE ANTIBODIES IN RHEUMATIC FEVER AND OTHER DISEASES.

Authors:  E V HESS; C W FINK; A TARANTA; M ZIFF
Journal:  J Clin Invest       Date:  1964-05       Impact factor: 14.808

2.  Anti-heart autoantibodies in ischaemic heart disease patients.

Authors:  D T Golan; A Kursbaum
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330

3.  Characterisation of immunofluorescent heterophile antibodies which may be confused with autoantibodies.

Authors:  B R Hawkins; B L McDonald; R L Dawkins
Journal:  J Clin Pathol       Date:  1977-04       Impact factor: 3.411

4.  Immunology of bovine heart valves. II. Reaction with connective tissue components.

Authors:  E Kasp-Grochowska; D Kingston; L E Glynn
Journal:  Ann Rheum Dis       Date:  1972-07       Impact factor: 19.103

5.  Antibodies against heterologous connective-tissue cells in rheumatic fever.

Authors:  T A Danilova; N M Fedorova
Journal:  Bull Exp Biol Med       Date:  1974-12       Impact factor: 0.804

6.  The significance of cardiolipin immunofluorescence (CLF).

Authors:  J M Wright; D Doniach
Journal:  Proc R Soc Med       Date:  1971-04

7.  Heart-reactive antibody associated with rheumatic fever: characterization and diagnostic significance.

Authors:  J B Zabriskie; K C Hsu; B C Seegal
Journal:  Clin Exp Immunol       Date:  1970-08       Impact factor: 4.330

8.  Smooth muscle antibody in bronchial asthma.

Authors:  M Turner-Warwick; P Haslam
Journal:  Clin Exp Immunol       Date:  1970-07       Impact factor: 4.330

9.  Study on streptococcus group A antigens common with heart tissue elements.

Authors:  I M Lyampert; O I Vvedenskaya; T A Danilova
Journal:  Immunology       Date:  1966-10       Impact factor: 7.397

Review 10.  Immunopathogenesis of rheumatic fever and rheumatic heart disease-current concepts.

Authors:  K S Reddy; P S Rao; M L Bhatia
Journal:  Indian J Pediatr       Date:  1982 Nov-Dec       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.